Streetbeat News

Earnings

CEVA

CEVA reported Q3 earnings of $0.02 per share, missing the analyst consensus estimate of $0.04 by 50%. The company's quarterly sales were $24.07 million, missing the estimate of $27.64 million by 12.91%. This represents a 90% decrease in earnings and a 28.48% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:21 pm

CRL

Charles River Laboratories has revised its FY2023 adjusted EPS guidance from $10.30-$10.90 to $10.50 - $10.70, which is in line with the estimate of $10.56. The company's revenue growth guidance for 2023 has been narrowed from 2.5% – 4.5% to 2.5% – 3.5%.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:20 pm

REFI

Chicago Atlantic Real (NASDAQ:REFI) reported Q3 earnings of $0.57 per share, beating the analyst consensus estimate of $0.52 by 9.62%. However, the company's quarterly sales of $13.73 million missed the analyst consensus estimate of $15.16 million by 9.41%. This represents a 1.72% decrease in earnings and a 6.19% increase in sales compared to the same period last year.

Portfolio Pulse from bharat@benzinga.com

November 08, 2023 | 12:19 pm

INVZ

Innoviz Technologies has reiterated its FY23 revenue outlook of $15M-$20M, against an estimate of $17.19M. The company also expects Q4 2023 revenue to be between $9M-$14M, compared to an estimate of $11.8M. Other financial targets for 2023 include 1-3 additional programs with existing customers, 2 new series production awards with new customers, cash collection from customers in the range of $20-30 million, and net new NRE bookings in the range of $20-70 million.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:18 pm

BLK

OXY

Occidental Petroleum Corp (OXY) reported Q3 FY23 revenue of $7.40 billion, beating consensus estimates. Production exceeded guidance, with Permian volumes at the high end of guidance. Pre-tax income was $2.0 billion, down from $3.3 billion a year ago. The company has completed around 60% of its $3.0 billion share repurchase program. BlackRock Inc (BLK) plans to invest $550 million in OXY's STRATOS project in Texas.

Portfolio Pulse from Lekha Gupta

November 08, 2023 | 12:17 pm

CRGE

Charge Enterprises (NASDAQ:CRGE) reported Q3 2023 earnings per share (EPS) of $(0.05), in line with analyst consensus. However, the company's quarterly sales of $132.28M missed the estimate of $143.78M by 8.00%. This represents a 200% decrease in EPS and a 28.83% decrease in sales compared to the same period last year.

Portfolio Pulse from vinayak@benzinga.com

November 08, 2023 | 12:17 pm

TNGX

Tango Therapeutics reported a Q3 cash position of $360 million, which provides the company with a cash runway into 2026.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:16 pm

VERI

Veritone has revised its FY23 revenue forecast to $126.4M-$128.0M, down from the previous estimate of $128M-$135M. The company also expects a non-GAAP net loss of $36M-$37M, higher than the previous range of $28M-$33M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:16 pm

EVGO

EVgo has updated its full year 2023 guidance, raising its sales forecast from $120-150 million to $148-158 million. The company also expects to have a total of 3,400 – 3,700 DC fast charging stalls in operation or under construction by the end of 2023.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:15 pm

TNGX

Tango Therapeutics (NASDAQ:TNGX) reported Q3 losses of $(0.23) per share, beating the analyst consensus estimate of $(0.34) by 32.35%. The company's quarterly sales were $10.73 million, surpassing the analyst consensus estimate of $7.32 million by 46.61%. This represents a 55.09% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:15 pm